II. Indications
- Left-sided Congestive Heart Failure
- First line agent for NYHA Class III or IV Heart Failure, in conjunction with ACE Inhibitor and Beta Blocker
- Monitor for Hyperkalemia (esp. with ACE Inhibitor) and renal dysfunction
- May use Eplerenone as an alternative (but more expensive)
- Edematous States
- Hyperandrogenism in women
-
Hyperaldosteronism
- First-line treatment for Hyperaldosteronism
- Refractory Hypertension
III. Contraindications
- Anuria
- Renal Insufficiency with Serum Creatinine over 2.4 mg/dl (GFR <30 ml/minute/1.73m2)
- Hyperkalemia (Serum Potassium >5 meq/L)
IV. Mechanism
-
Potassium-Sparing Diuretic via Aldosterone blockade
- Spironolactone is a Aldosterone competitive inhibitor
- Acts at distal convoluted renal tubule
- Inhibits Sodium retention
-
Congestive Heart Failure
- Works synergistically with ACE Inhibitors in CHF
-
ACE Inhibitors block Angiotensin II production
- Renal response is to increase Aldosterone
- Spironolactone blocks Aldosterone escape
V. Drug Interactions
- P-Glycoprotein Inhibitor
- Increased Serum Potassium (Hyperkalemia risk)
- Potassium Supplementation
- NSAIDs
- ACE Inhibitor
- Trimethoprim-Sulfamethoxazole
-
Salicylates
- Decrease Spironolactone effect
-
Digoxin
- Increased Digoxin Toxicity risk via increased Digoxin half life
-
Norepinephrine
- Decreases NorepinephrineVasopressor activity
VI. Dosing
-
Congestive Heart Failure
- Start 12.5 mg orally daily
- May increase to 25 mg orally daily after 4 weeks (up to 50 mg, but increased risk of Hyperkalemia)
- Monitor Serum Potassium at 3 days, 7 days and then monthly for the first 3 months
-
Edema
- Dose: 50 to 100 mg orally per day divided once to twice daily
- Maximum: 200 mg/day
-
Hyperandrogenism
- Dose: 50 mg orally twice daily
-
Hypertension
- Dose: 12.5 to 50 mg orally daily
- Maximum: 100 mg
-
Primary Hyperaldosteronism
- Dose: 100 to 400 mg/day preoperatively
- Use the lowest effective dose
VII. Monitoring
VIII. Pharmacokinetics
IX. Adverse Effects
- See Potassium-Sparing Diuretic
- Gynecomastia (in men)
- Mastodynia
- Erectile Dysfunction
- Alopecia
-
Hyperkalemia
- Avoid excessive Dietary Potassium
X. Safety
- Pregnancy Category C
- Safe in Lactation
XI. Resources
- Spironolactone (DailyMed)
XII. References
- (2017) Presc Lett 24(12): 69
- Margo (2001) Am Fam Physician 64(8):1393-8 [PubMed]
- Pitt (1999) N Engl J Med 341:709-17 [PubMed]
Images: Related links to external sites (from Bing)
Related Studies
spironolactone (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
SPIRONOLACTONE 100 MG TABLET | Generic | $0.18 each |
SPIRONOLACTONE 25 MG TABLET | Generic | $0.05 each |
SPIRONOLACTONE 50 MG TABLET | Generic | $0.10 each |
SPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB | Generic | $0.58 each |